As Lilly delivers medicines with speed and purpose, patient safety during clinical trials remains one of Lilly’s top priorities. This week, we welcome back our host Brian Winger, Lilly’s Associate Vice President, Digital Health Research and Development, Xiangnan Dang, Director of Engineering, and guests from Part 1, Tony Fantana and Chuck Benson. Guests on this episode will dive into the uniqueness of this technology; its effects and benefits to clinical trials; and, what’s next for Lilly in...

More than six million people currently live with Alzheimer’s disease and an additional five thousand are undiagnosed. Fighting and advocating for a disease without any treatment requires courage and resilience – as well as kindness and patience in the face of fear. On this episode of The Elixir Factor, Jim and Geri Taylor share their story of fighting this disease with courage and resilience, and finding ways to appreciate life together despite a chronic diagnosis.

When the COVID-19 pandemic hit, it changed the way we operate across countless areas of our lives. Now, many people are assessing what changes should remain moving forward. At Lilly, where we’re focused on developing medicines that will make life better for people around the world, we’re harnessing what we’ve learned to advance our work and asking ourselves: What lessons from the pandemic can we apply to improve clinical trials? The answer: Quite a few. On this episode of The Elixir Factor,...

Medical innovation happens through clinical trials—but many minority or marginalized communities are not as likely to participate, for a number of reasons. Low participation contributes to this health inequality as clinical trials can help give patients the opportunity to participate in and benefit from new medicine development. This week, guest host Brandy Matthews, associate vice president of global and U.S. medical affairs at Lilly, talks with Ralph and Mollie Richards, and Natalie Cheung...

Team USA athletes represent what’s possible with good health and commitment. Lilly is a proud partner of Team USA and on this special edition episode of the Elixir Factor, Joe talks with Allysa Seely, U.S. Paralympic Triathlon gold medalist, about her love for triathlons, living with migraine, and what it takes to keep going during challenging times. Migraine is a severely painful and debilitating neurologic disease that impacts 37 million adults in the U.S., 1 in 7 people worldwide, and is...

Imagine one day if there was a way to treat or even cure a genetic disease with a single injection? Genome-editing technologies provide the possibility to correct genetic problems at their source by precisely editing the DNA of a living organism. These methods have the potential to transform how a variety of diseases are treated, including a group of genetic disorders characterized by muscle weakness also called muscular dystrophies. Duchenne is the most common and severe form, caused by loss...

Everyone deserves a chance to reach their potential. Last summer, every U.S. Olympian and Paralympian’s potential was put on hold. And this past year, the entire world was held back by the largest health crisis in our lifetime. Lilly is a proud partner of Team USA and on this special edition episode of the Elixir Factor, Joe talks with Oz Sanchez, a three-time Paralympian about the factors that inspired his passion for cycling after a paralyzing accident and how his fearless mindset was...

Lilly has brought its scientific and medical expertise front and center to attack the coronavirus pandemic around the world. External collaboration, speed, and expertise are key to driving solutions that help our scientists and researchers uncover new way to measure, understand, and treat diseases, especially COVID-19. The experience gained fighting a pandemic will change the way we work forever. Joe talks with Dan Skovronsky, chief scientific officer and President of Lilly Research...

Kids have a ton of insight and the healthcare industry has a lot to learn from them. For starters, their situations are so unique, ranging from specialized peer dynamics to school activities to autonomy differences, etc. Pediatric research takes collaboration from many stakeholders including regulators, clinicians, industry experts, payers. Let’s not forget parents, caregivers and the patients for it to be successful. iCAN, International Children’s Advisory Network, is empowering pediatric...

There were more than 2 million cases of breast cancer diagnosed in 2018 worldwide. While there are more than 3.8 million survivors in the U.S., which is more than any other group of cancer survivors, breast cancer is actually a very complex disease with many different subsets. Often times, it is informed decisions that allow patients to feel more confident about their treatment. Awareness is crucial to better outcomes, but the messaging should be broad and informative as a breast cancer...

Good science drives innovation. One of the most critical ingredients for an innovation-friendly environment is a strong intellectual property (IP) framework. It allows for collaboration, partnership and larger investments that provide an opportunity to scale research, which in turn can provide a great opportunity for success, and hopefully advance the development of medicines for patients. The U.S. is the global leader of biopharmaceutical innovation because its IP system promotes...

Dominantly Inherited Alzheimer’s Disease (DIAD) is a rare form of Alzheimer’s disease that causes memory loss and dementia in people typically in their 30s to 50s. The disease affects less than 1 percent of the total population and is devastating to those who are impacted by it, including their families. Joe talks to Dr. Randy Bateman, the Charles F. and Joanne Knight Distinguished Professor of Neurology, director and principal investigator of DIAN-TU and Dr. Roy Yaari, senior medical advisor...

Health literacy is about a person’s ability to not just read, but to understand and act on health information to help optimize health outcomes. Patients are more responsible for their own health education than ever before. Clear health communication is one of the easiest ways to help those with limited health literacy. During this global COVID-19 pandemic, there has been an overflow of conflicting health information. Joe talks to Dr. Linda Neuhauser, Clinical Professor of Community Health and...

The promise of science to change people’s lives has never been greater. Recent progress in understanding biology, including the sequencing of the human genome, has led to new insights — allowing scientists more power and precision to treat disease, including cancer. As the understanding of cancer grows, scientists have found that it’s actually not a single disease but a collection of diseases that are driven by various causes or genetic breakdowns. Joe talks to Pete Nicholas, co-founder of...

Brain health is one of the most urgent issues for our healthcare system, our economy, and our country. Evidence is strong that people can reduce their risk of cognitive decline by making conscious lifestyle changes like regular physical activity and participating in social engagements. Joe talks to Brooks Kenny, Executive Director of WomenAgainstAlzheimer’s, about the factors that inspired the launch of The Be Brain Powerful® Campaign and its goals to change the path for both women and brain...

What is the body’s largest organ, coming in a variety of colors and weighing in at about 6 pounds? The skin. It’s one of the most familiar aspects of our bodies and our health. Skin related diseases are more than skin deep and can have devastating effects on people’s lives. There are an estimated 10 million patients in the U.S. with moderate-to-severe-atopic dermatitis. Joe talks with two of our own Lilly scientists, Dr. Lotus Mallbris and Alison Budelsky, about the unmet needs for patients...